Product Portfolio Expansion Sientra's recent acquisition of BIOCORNEUM, a state-of-the-art silicone gel scar treatment brand, opens up cross-selling opportunities to plastic surgeons who may be interested in offering complementary products to their patients undergoing breast procedures.

Technology Integration By leveraging tech solutions like JazzHR and Mastercard in their operations, Sientra demonstrates a commitment to efficiency and innovation. This tech-savvy approach could appeal to clinics looking to partner with a forward-thinking supplier.

International Market Entry The launch of High-Strength Cohesive Silicone Gel Breast Implants in Canada presents a chance for expansion into new markets. Sales teams could explore partnerships with Canadian plastic surgery practices seeking cutting-edge implant options.

Strategic Asset Sales Through asset sales to Tiger BioSciences LLC and Morningstar, Sientra has restructured its business while potentially unlocking capital for reinvestment. This reshaping could create opportunities for vendors offering complementary services or solutions.

Staff Reduction Impact Following a reduction in headcount and office closures, sales professionals could find opportunities to engage with remaining employees who may need support, training, or new suppliers as the company undergoes changes.